Phase 2 Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with anaplastic thyroid cancer, confirmed by lab testing of a tissue sample, and surgery to fully remove the cancer is not possible
- You are 18 years of age or older
- You are reasonably active and able to care for yourself in daily life (this is measured on a standard scale — confirm with trial site)
- Your heart, liver, kidneys, and blood counts are working well enough to handle treatment
- You are able to read and sign a consent form agreeing to take part
Who may not be able to join:
- Your cancer has a specific gene change called BRAF V600 and you have not yet tried targeted treatments known as BRAF/MEK inhibitors for it
- You are experiencing significant coughing up of blood or serious bleeding, for example from the digestive system or from the tumor itself
- The tumor has grown into major blood vessels
- You have open wounds or abnormal passages (called fistulas) in the body
- You have a medical reason that prevents you from safely taking any of the drugs being studied in this trial
- Your overall health and activity level is significantly limited (the lower end of the standard scale mentioned above — confirm with trial site)
- You are currently taking medications that suppress your immune system on an ongoing basis
- You have previously taken part in a clinical trial involving experimental drugs
- You are pregnant or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +7(921)951-70-88
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective response rate; Progression-Free Survival; Safety and Tolerability assessment (Incidence of Treatment-Emergent Adverse Events)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.